Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Comperat

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
The Canadian Journal of Urology|April 21, 2015
Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center studySusanna Cattarino, Thomas Seisen, Sarah J Drouin, et al.
World Journal of Urology|October 12, 2012
Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumoursDavid R Yates, Morgan Rouprêt, Sarah J Drouin, et al.
World Journal of Urology|June 27, 2008
Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancerVincent Misraï, Morgan Rouprêt, Emmanuel Chartier-Kastler, et al.
BJU International|March 4, 2009
Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomyMorgan Rouprêt, Vincent Hupertan, Eva Comperat, et al.
Technology in Cancer Research & Treatment|February 18, 2020
Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced UltrasoundMichele Lamuraglia, Guillaume Barrois, Delphine Le Guillou-Buffello, et al.
World Journal of Urology|September 3, 2014
Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapyAlexandra Masson-Lecomte, Evanguelos Xylinas, Morgane Bouquot, et al.
The Journal of Urology|March 19, 2015
Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller ProstatesArachk de Gorski, Morgan Rouprêt, Benoit Peyronnet, et al.
World Journal of Urology|December 24, 2011
Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examinationEvanguelos Xylinas, David R Yates, Raphaële Renard-Penna, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 15, 2008
[Can a standard treatment be proposed for penile cancer?]Jean-Nicolas Cornu, Eva Comperat, Raphaële Renard-Penna, et al.
BJU International|January 17, 2023
Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic riskOlivier Cussenot, Raphaele Renard-Penna, Sarah Montagne, et al.
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
The Canadian Journal of Urology|April 21, 2015
Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center studySusanna Cattarino, Thomas Seisen, Sarah J Drouin, et al.
World Journal of Urology|October 12, 2012
Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumoursDavid R Yates, Morgan Rouprêt, Sarah J Drouin, et al.
World Journal of Urology|June 27, 2008
Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancerVincent Misraï, Morgan Rouprêt, Emmanuel Chartier-Kastler, et al.
BJU International|March 4, 2009
Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomyMorgan Rouprêt, Vincent Hupertan, Eva Comperat, et al.
Technology in Cancer Research & Treatment|February 18, 2020
Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced UltrasoundMichele Lamuraglia, Guillaume Barrois, Delphine Le Guillou-Buffello, et al.
World Journal of Urology|September 3, 2014
Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapyAlexandra Masson-Lecomte, Evanguelos Xylinas, Morgane Bouquot, et al.
The Journal of Urology|March 19, 2015
Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller ProstatesArachk de Gorski, Morgan Rouprêt, Benoit Peyronnet, et al.
World Journal of Urology|December 24, 2011
Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examinationEvanguelos Xylinas, David R Yates, Raphaële Renard-Penna, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 15, 2008
[Can a standard treatment be proposed for penile cancer?]Jean-Nicolas Cornu, Eva Comperat, Raphaële Renard-Penna, et al.
BJU International|January 17, 2023
Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic riskOlivier Cussenot, Raphaele Renard-Penna, Sarah Montagne, et al.
Pageof 16